Cronos Group, Inc. (CRON)
3.295
-0.06
(-1.93%)
USD |
NASDAQ |
Oct 30, 12:38
Cronos Group Market Cap : 1.222B for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 29, 2026 | 1.246B |
| October 28, 2026 | 1.242B |
| October 27, 2026 | 1.253B |
| October 26, 2026 | 1.227B |
| October 23, 2026 | 1.242B |
| October 22, 2026 | 1.277B |
| October 21, 2026 | 1.257B |
| October 20, 2026 | 1.216B |
| October 19, 2026 | 1.205B |
| October 16, 2026 | 1.190B |
| October 15, 2026 | 1.186B |
| October 14, 2026 | 1.171B |
| October 13, 2026 | 1.186B |
| October 12, 2026 | 1.190B |
| October 09, 2026 | 1.197B |
| October 08, 2026 | 1.194B |
| October 07, 2026 | 1.201B |
| October 06, 2026 | 1.218B |
| October 05, 2026 | 1.205B |
| October 02, 2026 | 1.196B |
| October 01, 2026 | 1.190B |
| September 30, 2026 | 1.223B |
| September 29, 2026 | 1.253B |
| September 28, 2026 | 1.264B |
| September 25, 2026 | 1.238B |
| Date | Value |
|---|---|
| September 24, 2026 | 1.231B |
| September 23, 2026 | 1.260B |
| September 22, 2026 | 1.272B |
| September 21, 2026 | 1.235B |
| September 18, 2026 | 1.242B |
| September 17, 2026 | 1.249B |
| September 16, 2026 | 1.220B |
| September 15, 2026 | 1.186B |
| September 14, 2026 | 1.199B |
| September 11, 2026 | 1.164B |
| September 10, 2026 | 1.171B |
| September 09, 2026 | 1.170B |
| September 08, 2026 | 1.181B |
| September 04, 2026 | 1.209B |
| September 03, 2026 | 1.209B |
| September 02, 2026 | 1.201B |
| September 01, 2026 | 1.253B |
| August 31, 2026 | 1.249B |
| August 28, 2026 | 1.253B |
| August 27, 2026 | 1.257B |
| August 26, 2026 | 1.316B |
| August 25, 2026 | 1.301B |
| August 24, 2026 | 1.264B |
| August 21, 2026 | 1.227B |
| August 20, 2026 | 1.194B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Lexaria Bioscience Corp. | 5.321M |
| Target Group, Inc. (Canada) | 0.617M |
| InMed Pharmaceuticals, Inc. | 8.543M |
| XORTX Therapeutics, Inc. | 1.757M |
| NervGen Pharma Corp. | 145.79M |
Market Cap Related Metrics
| PE Ratio | 17.89 |
| PS Ratio | 7.012 |
| PEG Ratio | 0.0624 |
| Price to Book Value | 1.143 |
| Price to Free Cash Flow | 25.31 |
| Price | 3.295 |
| Earnings Yield | 5.59% |
| PEGY Ratio | 0.0624 |
| Normalized PE Ratio | 16.64 |